Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD)

Journal of Neurology

Volumn 261, Issue 11, 2014, Pages 2204-2208

  De Rosa, Anna ^a   Carducci, Claudia ^b   Carducci, Carla ^b   Peluso, Silvio ^a   Lieto, Maria ^a   Mazzella, Andrea ^a   Saccà, Francesco ^a   Brescia Morra, Vincenzo ^a   Pappatà, Sabina ^c   Leuzzi, Vincenzo ^b   De Michele, Giuseppe ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CNR   (Italy)

Author keywords

Dopa responsive dystonia; GTP cyclohydrolase1; SWEDD; 123I FP CIT SPECT

Indexed keywords

BIOPTERIN; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; IODINE 123; NEOPTERIN; PHENYLALANINE;

ADULT; AGED; ARTICLE; BIOCHEMICAL COMPOSITION; BRADYKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOPA RESPONSIVE DYSTONIA; DYSKINESIA; DYSTONIA; FEMALE; GENE MUTATION; HUMAN; HYPOTHESIS; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PARKINSONISM; PRIORITY JOURNAL; SCANS WITHOUT EVIDENCE OF DOPAMINERGIC DEFICIENCY; SEGMENTAL DYSTONIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR; DYSTONIC DISORDERS; GENETIC SCREENING; GENETICS; PROCEDURES;

ADULT; AGED; DYSTONIC DISORDERS; FEMALE; GENETIC TESTING; GTP CYCLOHYDROLASE; HUMANS; MALE; MIDDLE AGED;

EID: 84920942539     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7477-6     Document Type: Article

References (28)

1. Parkinson Study Group (2002) Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 287:1653–1661
2. Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ, REAL-PET Study Group (2003) Slower progression of Parkinson’s disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol 54:93–101
3. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K, Parkinson Study Group (2004) Levodopa and the progression of Parkinson’s disease. N Engl J Med 351:2498–2508
4. Marshall VL, Patterson J, Hadley DM, Grosset KA, Grosset DG (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Commun 27:933–937
5. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:861–870
6. Silveira-Moriyama L, Schwingenschuh P, O’Donnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP, Lees AJ (2009) Olfaction in patients with suspected Parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 80:744–748
7. Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, Quinn N, Bhatia KP (2007) Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 22:2210–2215
8. Schwingenschuh P, Ruge D, Edwards MJ, Terranova C, Katshnig P, Carrillo F, Laura Silveira-Moriyama L, Schneider SA, Kägi G, Dickson J, Lees AJ, Quinn N, Mir P, Rothwell JC, Bhatia KP (2010) Adult onset asymmetric upper limb tremor misdiagnosed as Parkinson’s disease: a clinical and electrophysiological study. Mov Disord 25:560–569
9. Segawa M (2003) Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5). Chang Gung Med J 32:1–11
10. Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, Fujita K, Nagatsu T (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8:236–242
11. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S (1990) Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 40:66–69
12. Trender-Gerhard I, Sweeney MG, Schwingenschuh P, Mir P, Edwards MJ, Gerhard A, Polke JM, Hanna MG, Davis MB, Wood NW, Bhatia KP (2009) Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry 80:839–845
13. 123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 43:792–800
14. Furukawa Y, Nishi K, Kondo T, Mizuno Y, Narabayashi H (1993) CSF biopterin levels and clinical features of patients with juvenile parkinsonism. Adv Neurol 60:562–567
15. Bandmann O, Goertz M, Zschocke J, Deuschl G, Jost W, Hefter H, Müller U, Zöfel P, Hoffmann G, Oertel W (2003) The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 60:700–702
16. Erro R, Picillo M, Vitale C, Amboni M, Moccia M, Longo K, Cozzolino A, Giordano F, De Rosa A, De Michele G, Pellecchia MT, Barone P (2013) Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients. J Neurol Neurosurg Psychiatry 84:14–17
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
18. Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54:S32–S45
19. Antonozzi I, Carducci C, Vestri L, Pontecorvi A, Moretti F (1988) Rapid and sensitive method for high-performance liquid chromatographic analysis of pterins in biological fluids. J Chromatogr 459:319–324
20. Hyland K, Fryburg JS, Wilson WG, Bebin EM, Arnold LA, Gunasekera RS, Jacobson RD, Rost-Ruffner E, Trugman JM (1997) Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 48:1290–1297
21. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF (1993) Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 39:66–71
22. Saunders-Pullmana R, Blau N, Hyland K, Zschocke J, Nygaard T, Raymond D, Shanker V, Mohrmann K, Arnold L, Tabbal S, deLeon D, Ford B, Brin M, Chouinard S, Ozelius L, Klein C, Bressman SB (2004) Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Mol Genet Metabol 83:207–212
23. Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink MH, Sips HJ, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, Lees AJ, Costa DC, Gacinovic S, Oertel WH, Pogarell O, Hoeffken H, Joseph K, Tatsch K, Schwarz J, Ries V (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15:503–510
24. Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K (2004) (23I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 61:1224–1229
25. Utiumi MA, Felício AC, Borges CR, Braatz VL, Rezende SA, Munhoz RP, Bressan RA, Ferraz HB, Teive HA (2012) Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs). Arq Neuropsiquiatr 70:667–673
26. Sixel-Doring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C (2011) The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 258:2147–2154
27. Marek K, Seibyl J, Eberly S, Oakes D, Shoulson I, Lang AE, Hyson C, Jennings D, Parkinson Study Group PRECEPT Investigators (2014) Longitudinal follow-up of SWEDD subjects in the PRECEPT study. Neurology 82:1791–1797
28. Leuzzi V, Carducci C, Chiarotti F, D’Agnano D, Giannini MT, Antonozzi I, Carducci C (2013) Urinary neopterin and phenylalanine loading test as tools for the biochemical diagnosis of Segawa disease. JIMD Rep 7:67–75